OCT 05, 2016 12:00 PM PDT

Sensitive and Specific, Multiplex, Real-Time PCR Assays for Assessing the Abundance of Extremely Rare Mutations Associated with Cancer Diagnosis, Prognosis, and Therapy

Speaker

Abstract

Real-time multiplex PCR assays are potentially the most rapid, most sensitive,
and least expensive way to assess the abundance of mutant DNA fragments present in liquid biopsies; provided that a way is found to selectively amplify rare mutant fragments without amplifying abundant related wild-type fragments; and provided that the amplicons generated from different mutants that occur in the same or an adjacent codon are prevented from forming heteroduplexes that interfere with exponential amplification, obscuring the threshold values of the rarer mutants.  “SuperSelective” PCR primers, due to their unique design, are extraordinarily specific, able to selectively initiate the synthesis of amplicons
on ten mutant DNA fragments in the presence of 1,000,000 wild-type DNA fragments,
even though the only difference between the mutant and the wild-type is a single-nucleotide polymorphism.  Moreover, each SuperSelective primer that is specific for a particular mutation possesses a unique 5' tag sequence that is incorporated into the resulting amplicons and detected in real-time by differently colored molecular beacon probes. 
Each SuperSelective primer specific for a particular mutation also possesses a unique “bridge” sequence that assures that each primer only copies its intended amplicon,
and that creates a single-stranded bubble in heteroduplexes that enables the rarest amplicons to be independently exponentially amplified.  And finally, the inclusion of primers for a wild-type reference gene fragment, enables the abundance of each type of mutant
DNA fragment to be assessed (without measuring the amount of DNA in the sample)
by determining the difference between its threshold value and the threshold value of
the reference gene.
 


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
MAY 18, 2021 8:00 AM PDT
C.E. CREDITS
MAY 18, 2021 8:00 AM PDT
Date: May 18, 2021 Time: 8:00am (PST) The global pandemic has caused an increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provide qu...
OCT 20, 2021 10:00 AM PDT
C.E. CREDITS
OCT 20, 2021 10:00 AM PDT
Date: October 20, 2021 Time:10:00am (PDT), 1:00pm (EDT) As the prevalence of Diabetes continues to rise in many areas across the globe, healthcare providers continue to look for methods that...
OCT 05, 2016 12:00 PM PDT

Sensitive and Specific, Multiplex, Real-Time PCR Assays for Assessing the Abundance of Extremely Rare Mutations Associated with Cancer Diagnosis, Prognosis, and Therapy


Specialty

Molecular Diagnostics

Cancer Research

Biotechnology

Clinical Diagnostics

Molecular Biology

Clinical Research

Cell Biology

Immunology

Cell Culture

Dna Sequencing

Gene Expression

Cancer Diagnostics

Virology

Lab Automation

Dna

Geography

North America50%

Asia38%

Europe13%

Registration Source

Website Visitors100%

Job Title

Clinical Laboratory Scientist29%

Student29%

Medical Laboratory Technician29%

Educator/Faculty14%

Organization

Academic Institution38%

Hospital25%

Clinical Laboratory25%

Manufacturer - Other13%


Show Resources
Loading Comments...
Show Resources